A NEW METHOD OF TARGET PREPARATION FOR MEASURING STOPPING POWERS OF METALS FOR CHANNELED IONS IN THE LOW ENERGY REGION = NOUVELLE METHODE DE PREPARATION DE CIBLES POUR MESURER LES POUVOIRS D'ARRET DES METAUX POUR DES IONS CANALISES DANS LA REGION DE BASSE ENERGIEMERTLER G; FEHSE B; KOPITZKI K et al.1979; RAD. EFFECTS; GBR; DA. 1979; VOL. 45; NO 1-2; PP. 53-56; BIBL. 7 REF.Article

Insertional mutagenesis and clonal dominance : biological and statistical considerationsFEHSE, B; ROEDER, I.Gene therapy (Basingstoke). 2008, Vol 15, Num 2, pp 143-153, issn 0969-7128, 11 p.Article

Fachteil. Recycling im E/E-Bereich; Möglichkeiten und Grenzen = Recycling in e/e-field, possibilities and limitsFEHSE, B; HÄHNSEN, H; KIRCHER, K et al.Plastverarbeiter. 1995, Vol 46, Num 4, pp 28-34, issn 0032-1338, 6 p.Article

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44⁺) and T (HLA-DR⁺) cellsLIOZNOV, M; EL-CHEIKH, J; FEHSE, B et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 2, pp 349-353, issn 0268-3369, 5 p.Article

Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, ΔTrkAMEYER, J; RHEIN, M; REUTHER, G. W et al.Leukemia. 2007, Vol 21, Num 10, pp 2171-2180, issn 0887-6924, 10 p.Article

Minimal residual disease diagnostics in myeloid malignancies in the post transplant periodBACHER, U; ZANDER, A. R; HAFERLACH, T et al.Bone marrow transplantation (Basingstoke). 2008, Vol 42, Num 3, pp 145-157, issn 0268-3369, 13 p.Article

Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutationsMETZNER, A; HORSTMANN, M. A; FEHSE, B et al.Gene therapy (Basingstoke). 2007, Vol 14, Num 8, pp 699-703, issn 0969-7128, 5 p.Article

Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69)FEHSE, B; FRERK, O; GOLDMANN, M et al.British journal of haematology. 2000, Vol 109, Num 3, pp 644-651, issn 0007-1048Article

Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donorsNETH, O. W; BACHER, U; THIEBAUT, R et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 1, pp 13-19, issn 0268-3369, 7 p.Article

Lentiviral gene ontology (LeGO) vectors equipped with novel drug-selectable fluorescent proteins: new building blocks for cell marking and multi-gene analysisWEBER, K; MOCK, U; PETROWITZ, B et al.Gene therapy (Basingstoke). 2010, Vol 17, Num 4, pp 511-520, issn 0969-7128, 10 p.Article

Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplantsLIOZNOV, M. V; FREIBERGER, P; KRÖGER, N et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 9, pp 909-914, issn 0268-3369, 6 p.Article

Highly-efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectinFEHSE, B; SCHADE, U. M; ZHIXIONG LI et al.British journal of haematology. 1998, Vol 102, Num 2, pp 566-574, issn 0007-1048Article

Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCTALCHALBY, H; BADBARAN, A; BOCK, O et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 9, pp 1404-1407, issn 0268-3369, 4 p.Article

Pois(s)on: It's a question of dose..FEHSE, B; KUSTIKOVA, O. S; BUBENHEIM, M et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 11, pp 879-881, issn 0969-7128, 3 p.Article

Self-inactivating retroviral vectors with improved RNA processingKRAUNUS, J; SCHAUMANN, D. H. S; BAUM, C et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 21, pp 1568-1578, issn 0969-7128, 11 p.Article

Bicistronic retroviral vectors for combining myeloprotection with cell-surface markingHILDINGER, M; SCHILZ, A; ECKERT, H.-G et al.Gene therapy (Basingstoke). 1999, Vol 6, Num 7, pp 1222-1230, issn 0969-7128Article

Reduced proliferation of CD34⁺ cells from patients with acute myeloid leukemia after gene transfer of INPP5DMETZNER, A; PRECHT, C; FEHSE, B et al.Gene therapy (Basingstoke). 2009, Vol 16, Num 4, pp 570-573, issn 0969-7128, 4 p.Article

Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BMLIOZNOV, M; DELLBRÜGGER, C; SPUTTEK, A et al.Bone marrow transplantation (Basingstoke). 2008, Vol 42, Num 2, pp 121-128, issn 0268-3369, 8 p.Article

Stem cell clonality and genotoxicity in hematopoietic cells: Gene activation side effects should be avoidableVON KALLE, C; FEHSE, B; LAYH-SCHMITT, G et al.Seminars in hematology. 2004, Vol 41, Num 4, pp 303-318, issn 0037-1963, 16 p.Article

The inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitroHORN, S; MEYER, J; HEUKESHOVEN, J et al.Leukemia. 2001, Vol 15, Num 1, pp 112-120, issn 0887-6924Article

Allogeneic stem-cell transplantation in patients with refractory acute leukemia : a long-term follow-upOYEKUNLE, A. A; KRÖGER, N; ZANDER, A. R et al.Bone marrow transplantation (Basingstoke). 2006, Vol 37, Num 1, pp 45-50, issn 0268-3369, 6 p.Article

Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functionsGIORDANO, F. A; FEHSE, B; ZELLER, W. J et al.Bone marrow transplantation (Basingstoke). 2006, Vol 38, Num 3, pp 229-235, issn 0268-3369, 7 p.Article

Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3β signaling and leads to an increased transit time through the G1 phase of the cell cycleHORN, S; ENDL, E; FEHSE, B et al.Leukemia. 2004, Vol 18, Num 11, pp 1839-1849, issn 0887-6924, 11 p.Article

A novel 'sort-suicide' fusion gene vector for T cell manipulationFEHSE, B; KUSTIKOVA, O. S; BAUM, C et al.Gene therapy (Basingstoke). 2002, Vol 9, Num 23, pp 1633-1638, issn 0969-7128, 6 p.Article

Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirementsAYUK, F. A; LI, Z; KÜHLCKE, K et al.Gene therapy (Basingstoke). 1999, Vol 6, Num 10, pp 1788-1792, issn 0969-7128Article